Interactions Between Diet, Intestinal Microbiota and Metabolomics
Diet, Intestinal Microbiota and Metabolomics: Evaluation of Possible Synergies
1 other identifier
interventional
60
1 country
1
Brief Summary
It is widely known that the quality of the diet is able to modify the expression of many bacterial genes populating the intestine of the host, as well as the type of bacteria themselves. This is also expressed with a more or less evident and troublesome after meals symptomatology that many patients complain to the health care staff. A good composition of the microbiota is crucial for the health of the individual, both at the intestinal level as well as at the systemic level because, depending on the type of food substrate available at the intestinal level, metabolites will be produced capable of positively or negatively affect the health of the individual. In fact, scientific evidence shows the existence of the causal link between the health of the microbiota and the genesis of inflammatory diseases not only intestinal, but also systemic, and even of cancer, obesity, metabolic syndrome and atherosclerosis. The recent diffusion of gene sequencing techniques has brought significant developments in the study of the human and bacterial genome, which allow to produce enormous quantities of sequences at a lower cost and at a higher speed than previous techniques. Therefore the clinical Nutrition Clinic of the IRCCS De Bellis in Castellana Grotte (BA) proposes to check if changes in the intestinal microbiota correlate, not only with anthropometric and clinical-laboratory parameters, but also with the typical symptoms of irritable bowel syndrome (IBS), a functional pathology very widespread with the advent of the modern era, in which, a diet rich in sugars and proteins of animal origin and poor in plant foods, is unfortunately common also in the areas of the Mediterranean basin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2018
CompletedFirst Posted
Study publicly available on registry
March 23, 2018
CompletedStudy Start
First participant enrolled
April 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2019
CompletedMay 1, 2018
April 1, 2018
1 year
March 16, 2018
April 27, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Changes in weight
At baseline and after two months.
Study Arms (3)
Vegetarian diet
EXPERIMENTALPeople randomized to interventional groups will take a vegetarian diet (i.e. without animal products, except milk and eggs)
Low carbs
EXPERIMENTALPeople randomized to interventional groups will take a low carbs diet (i.e. with a limited amount of carbohydrates).
Mediterranean diet
ACTIVE COMPARATORPeople randomized to interventional groups will take a mediterranean diet (i.e. with low glycemic index carbohydrates and vegetables).
Interventions
People randomized to this interventional group will take a vegetarian diet (i.e. without animal products, except milk and eggs).
People randomized to this interventional group will take low carbs diet (i.e. with a limited amount of carbohydrates)
People randomized to this interventional group will take a traditional Mediterranean diet.
Eligibility Criteria
You may qualify if:
- No major comorbidities with a life expectancy less than 12 months;
- BMI between 29 and 33 kg/m2
- Serum cholesterol 200-260 mg/dl
- Serum triglycerides \> 150 mg/dl
You may not qualify if:
- Antibiotics or prebiotics in the 3 months before the enrollment;
- Use of statins or other medications for lowering cholesterol;
- Menopause;
- Previous history of cancer.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Azienda ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
Castellana Grotte, BARI, 70013, Italy
Related Publications (2)
Zimmer J, Lange B, Frick JS, Sauer H, Zimmermann K, Schwiertz A, Rusch K, Klosterhalfen S, Enck P. A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur J Clin Nutr. 2012 Jan;66(1):53-60. doi: 10.1038/ejcn.2011.141. Epub 2011 Aug 3.
PMID: 21811294BACKGROUNDTurnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007 Oct 18;449(7164):804-10. doi: 10.1038/nature06244.
PMID: 17943116BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Gastroenterology and Clinical Nutrition
Study Record Dates
First Submitted
March 16, 2018
First Posted
March 23, 2018
Study Start
April 1, 2018
Primary Completion
April 1, 2019
Study Completion
April 1, 2019
Last Updated
May 1, 2018
Record last verified: 2018-04